HTLV-III SEROLOGY DISTINGUISHES ATYPICAL AND ENDEMIC KAPOSI'S SARCOMA IN AFRICA
The LancetPublished 1 February 1985
Anne Bayley, R. Cheingsong‐Popov, Angus Dalgleish, R. G. Downing, Richard S. Tedder, Richard Weiss
Citations103
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Evidence is found of the emergence of a clinically atypical form of Kaposi's sarcoma in Africans, which resembles that seen in American patients with AIDS, and which is associated with HTLV-III infection.
Abstract
Serum samples from African patients with Kaposi's sarcoma and acquired-immuno-deficiency-syndrome-related (AIDS-related) disorders and from normal subjects in Uganda and Zambia were tested for antibodies to the human T-lymphotropic retroviruses (HTLV) types I, II, and III. Nearly 90% of patients with AIDS-related disorders or with atypical, aggressive Kaposi's sarcoma were seropositive for HTLV-III in both countries, whereas only 17% of patients with classic endemic Kaposi's sarcoma were seropositive. Among the controls 20% were seropositive for HTLV-III in Uganda but only 2% in Zambia. None of the subjects tested had antibodies to HTLV-I or HTLV-II. These results are further evidence of the emergence of a clinically atypical form of Kaposi's sarcoma in Africans, which resembles that seen in American patients with AIDS, and which is associated with HTLV-III infection. The low frequency of antibodies to HTLV-III in the normal Zambian population together with the first appearance of HTLV-III-associated diseases during the past 2 years suggests that this virus is new to Zambia, although it may have been present in Uganda for longer.
Keywords
Immunology and MicrobiologyAgricultural and Biological Sciences
ScienceIsolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)
6,880 Citations1983Françoise Barré‐Sinoussi, Jean‐Claude Chermann +10 more
From these studies it is concluded that this virus as well as the previous HTLV isolates belong to a general family of T-lymphotropic retroviruses that are horizontally transmitted in humans and may be involved in several pathological syndromes, including AIDS.
ScienceFrequent Detection and Isolation of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and at Risk for AIDS
3,645 Citations1984Robert C. Gallo, Syed Zaki Salahuddin +11 more
Peripheral blood lymphocytes from patients with the acquired immunodeficiency syndrome (AIDS) or with signs or symptoms that frequently precede AIDS (pre-AIDS) were grown in vitro with added T-cell growth factor and assayed for the expression and release of human T-lymphotropic retroviruses (HTLV).
MMWR Morbidity and Mortality Weekly ReportKaposis sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California.
1,044 Citations1981Alvin E. Friedman‐Kien, L Laubenstein +8 more
The LancetACQUIRED IMMUNODEFICIENCY SYNDROME IN RWANDA
573 Citations1984Philippe Van de Perre, Philippe Lepage +7 more
It is suggested that AIDS is present in central Africa as an entity probably unrelated to the well-known endemic African KS, and an association of an urban environment, a relatively high income, and heterosexual promiscuity could be a risk factor for AIDS in Africa.
TransplantationKAPOSIʼS SARCOMA IN ORGAN TRANSPLANT RECIPIENTS REPORT OF 20 CASES
347 Citations1979Israel Penn
There is an increased incidence of Kaposi's sarcoma in organ transplant recipients in whom it comprises more than 3% of all de novo neoplasms, and this variety has a bad prognosis.
The LancetSEROEPIDEMIOLOGICAL STUDIES OF HUMAN T-LYMPHOTROPIC RETROVIRUS TYPE III IN ACQUIRED IMMUNODEFICIENCY SYNDROME
245 Citations1984Bijan Safai, J E Groopman +6 more
Sera screened for antibodies to proteins of the novel human T-lymphotropic retrovirus (leukaemia virus), HTLV-III, recently isolated from cultured T cells of AIDS patients strongly indicate that the antibodies to HT LV are diagnostic of AIDS or indicate significant risk of the disease, and suggest that HT LV is the primary cause of human AIDS.
The LancetDETECTION OF IgG ANTIBODIES TO LYMPHADENOPATHY-ASSOCIATED VIRUS IN PATIENTS WITH AIDS OR LYMPHADENOPATHY SYNDROME
228 Citations1984Françoise Brun‐Vézinet, Françoise Barré‐Sinoussi +8 more
IgG antibodies to lymphadenopathy-associated virus ( LAV ) were found by a specific enzyme-linked immunosorbent assay in 18/48 (37.5%) patients with acquired immunodeficiency syndrome, patients with lymphadenopathic syndrome, 8/44 (18%) homosexual men without lymphadenectomy, and 1/100 unselected blood donors.
The LancetPREVALENCE OF ANTIBODY TO HUMAN T-LYMPHOTROPIC VIRUS TYPE III IN AIDS AND AIDS-RISK PATIENTS IN BRITAIN
228 Citations1984R. Cheingsong‐Popov, Richard Weiss +17 more
Sera reacting in a membrane immunofluorescence assay to HTLV-III were positive when tested against cells infected with lymphadenopathy virus (LAV-1), and cross-adsorption tests indicated that these retroviruses are probably identical.
The LancetACQUIRED IMMUNE DEFICIENCY SYNDROME IN BLACK AFRICANS
209 Citations1983Nathan Clumeck, F Mascart-Lemone +3 more
It is suggested that Black Africans may be another risk group for AIDS, and to the authors knowledge there has been no previous report of AIDS in healthy Black Africans with no history of homosexuality or drug abuse.
SciencePrevalence of Antibodies to Lymphadenopathy-Associated Retrovirus in African Patients with AIDS
123 Citations1984Françoise Brun‐Vézinet, C. Rouzioux +18 more
Serologic data suggest that LAV was present as early as 1977 in Zaire, and the presence of antibodies to lymphadenopathy-associated retrovirus (LAV) was determined by a radioimmunoprecipitation assay and an enzyme-linked immunosorbent solid assay of sera from Zairian patients with the acquired immune deficiency syndrome (AIDS) in 1983.
The LancetLOW PREVALENCE IN THE UK OF HTLV-I AND HTLV-II INFECTION IN SUBJECTS WITH AIDS, WITH EXTENDED LYMPHADENOPATHY, AND AT RISK OF AIDS
122 Citations1984Richard S. Tedder, D.C. Shanson +6 more
Infection by HTLV-I andHTLV-II retroviruses occurs more frequently in ELAS patients and drug addicts than in the UK population as a whole, but the low prevalence of these infections inELAS and AIDS patients indicates that these two strains of lymphotropic retrovirus have no aetiological role in ELas and AIDS.
The LancetAGGRESSIVE KAPOSI'S SARCOMA IN ZAMBIA, 1983
110 Citations1984AnneC. Bayley
8 of 13 patients with atypical KS failed to maintain an initial response to chemotherapy and died before the end of 1983, but there were no deaths amongst patients with endemic disease.
The LancetAFRICAN KAPOSI'S SARCOMA AND AIDS
53 Citations1984R. G. Downing, Roger Eglin +1 more
African patients with Kaposi's sarcoma seem to have an immunological and virological profile similar to that seen in American patients with AIDS.
International Journal of CancerEndemic Kaposi's sarcoma: Incidence and risk factors in the west Nile district Of Uganda
45 Citations1984Jolian McHardy, Edward H. Williams +4 more
Out of 72 Kaposi's sarcoma patients diagnosed between 1951 and March 1976 at Kuluva Hospital, West Nile District, Uganda, 64 with known co‐ordinates were plotted on a map and demonstrated that cases tended to be post‐pubertal males, a high proportion of whom had been bitten by a blood‐sucking insect identified as being similar to Haematopota.